Meiact Indications/Uses

Folliculitis, pyelonephritis, cystitis.
100 mg tablet and Fine granules for oral suspension: The following infections caused by cefditoren-susceptible strains of Staphylococcus sp., Streptococcus sp., Peptostreptococcus sp., Branhamella catarrhalis, Propionibacterium acnes, Escherichia coli, Citrobacter sp., Klebsiella sp., Enterobacter sp., Serratia sp., Proteus sp. (Proteus mirabilis, Proteus vulgaris), Morganella sp., Providencia sp., Haemophilus influenzae, Bacteroides sp., and Bordetella pertussis (for Fine granules for oral suspension only): Pharyngolaryngitis (throat abscess), acute bronchitis, tonsillitis (peritonsillitis, peritonsillar abscess), pneumonia; Otitis media, sinusitis; Superficial secondary infection in trauma, surgical wound, etc; Furuncle, furunculosis, carbuncle, impetigo, contagiosa, erysipelas, phlegmon, lymphangitis (lymphadenitis), suppurative perionychia (paronychia), subcutaneous abscess, infectious atheroma.
100 mg tablet: Chronic bronchitis, bronchiectasis with infection, secondary infection in chronic respiratory disease, pulmonary suppuration.
200 mg tablet: MEIACT is indicated for the treatment of the following infections caused by susceptible microorganisms (see Pharmacology: Pharmacodynamics under Actions): Acute pharyngo-tonsillitis; Acute maxillary sinusitis; Acute exacerbations of chronic bronchitis; Community-acquired pneumonia, mild to moderate; Uncomplicated skin and skin structure infections, such as cellulitis, infected wounds, abscesses, impetigo and boils.
Consideration should be given to official guidance on the appropriate use of antibacterial agents.
Fine granules for oral suspension: Urinary tract infections; Scarlet fever; Pertussis.